© 2026 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 161 Farringdon Rd, London EC1R 3AL. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions | Cookies

Emerging Markets

Top section

Data

More articles

More articles

More articles

  • A rush to dollars in recent days has caused dysfunctions in various corners of the financial markets. The US Federal Reserve has rushed to put out the flames, including with new measures on Monday.
  • The pace of emerging markets borrowers’ requests for official institution funding, amid the shocking deterioration of their bond markets, is picking up pace. On Sunday, Ukraine's president Volodymyr Zelensky said that he had discussed using International Monetary Fund resources to fight the economic impact of Covid-19.
  • The top officials at various Chinese regulatory bodies made efforts over the weekend to calm nerves on default risks and fleeing foreign capital as they tame the spread of the Covid-19 coronavirus within the country.
  • The China Securities Regulatory Commission (CSRC) has shed some light on the kinds of companies that are eligible to list on the Star board, solving part of a problem that has long puzzled potential IPO candidates.
  • Chinese biotechnology company InnoCare Pharma’s shares surged over 10% on their Monday debut, following an online opening ceremony for the HK$2.2bn ($288.7m) listing in Hong Kong.
  • Cambodia’s Acleda Bank has set the share price for its IPO after two roadshows events, but has extended the subscription period to accommodate the government’s coronavirus containment measures.